|
Index
|
Enhance Ethical Approaches to ResearchIn
many emergency situations, time is inadequate to allow a critically
ill patient or a surrogate decision maker to appropriately
consider the risks and benefits of participating in a research
study. There are two sets of regulations (Department of Health
& Human Services and Food and Drug Administration) concerning
the waiver of informed consent for medical research. These
two sets of regulations have created some confusion among
EMS researchers. Their implementation has exposed a fundamental
problem associated with conducting research with subjects
who cannot provide consent: There is a direct and irrevocable
tension between protecting the rights of research subjects
and the ability to investigate and improve the care rendered
to future patients. The current federal regulations on research
in emergency situations may have the unintended consequence
of ensuring that EMS professionals will provide care that
has not been scientifically validated. . New interventions
to treat critical illness will continue to be introduced into
the EMS environment, but difficulty in complying with the
requirements of the consent regulations may impede the ability
of EMS researchers to ensure that they have been studied appropriately
first. Recommendation 8.The Food and Drug Administration (FDA) and the Office for Human Research Protections (OHRP) should work with EMS research stakeholders to evaluate the current requirements for exception from informed consent in emergency situations and to identify those requirements that are serious impediments to conducting EMS research. The FDA, OHRP, and EMS research stakeholders should work together to develop and propose EMS-specific consent strategies as well as appropriate revisions to the existing regulations to reduce the impediments to research while continuing to adequately protect research subjects. ·
There
should be a national conference that brings together a large
variety of EMS research
stakeholders and regulators to recommend improvements to the
emergency exception to informed consent procedures. ·
Based
on the recommendations of the FDA and OHRP, Congress should
amend the laws governing exception from informed consent for
emergency research to reduce the regulatory burden and facilitate
research while continuing to protect the rights of
research subjects. · There should be educational programs that explain the consent process and recommend strategies by which EMS researchers can fulfill the requirements. · Educational programs that describe the difficulties in obtaining consent in the EMS environment, explain the emergency exception from consent process, and promote acceptance by and consistency among Institutional Review Board (IRBs) should be made available to IRB members and administrators. |